Article Versions Notes

Lee E-J, Hwang H-B, Han S-H, Ham Y-R, Shin J-A, Lee K-W, Na K-R, Choi D-E. Serum Growth Differentiation Factor-15/Albumin Ratio as a 2-Year Survival Marker of End-Stage Renal Disease Patients Initiating Maintenance Hemodialysis. Diagnostics. 2022; 12(2):257. https://doi.org/10.3390/diagnostics12020257

Lee, Eu-Jin, Haet-Bit Hwang, Soo-Hyun Han, Young-Rok Ham, Jin-Ah Shin, Kang-Wook Lee, Ki-Ryang Na, and Dae-Eun Choi. 2022. "Serum Growth Differentiation Factor-15/Albumin Ratio as a 2-Year Survival Marker of End-Stage Renal Disease Patients Initiating Maintenance Hemodialysis" Diagnostics 12, no. 2: 257. https://doi.org/10.3390/diagnostics12020257

Lee, E.-J., Hwang, H.-B., Han, S.-H., Ham, Y.-R., Shin, J.-A., Lee, K.-W., Na, K.-R., & Choi, D.-E. (2022). Serum Growth Differentiation Factor-15/Albumin Ratio as a 2-Year Survival Marker of End-Stage Renal Disease Patients Initiating Maintenance Hemodialysis. Diagnostics, 12(2), 257. https://doi.org/10.3390/diagnostics12020257